Mucocutaneous manifestations of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome: particular aspects in a Latin-American population
- 1 May 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 32 (3) , 250-255
- https://doi.org/10.1111/j.1365-2230.2007.02392.x
Abstract
Mucocutaneous lesions in human immunodeficiency virus (HIV)-infected patients with disseminated histoplasmosis have a wide spectrum of clinical manifestations, making its diagnosis difficult. Studies have been restricted to case reports and series with small numbers of patients not specifically focusing on the dermatological aspects of histoplasmosis. To describe the characteristics of mucocutaneous lesions of disseminated histoplasmosis in HIV-infected patients. A retrospective and prospective study was conducted on 36 HIV-infected patients with mucocutaneous histoplasmosis in a tertiary-care hospital in Brazil. Mucocutaneous histoplasmosis was diagnosed by histopathology in 33 of the 36 patients (91%) and/or culture in 23 (64%). Their CD4+ cell counts ranged from 2 to 103 cells/mm(3). The average number of different morphological types of lesions was three per patient. Despite the variability of the lesions, papules (50%), crusted papules (64%) and oral mucosal erosions and/or ulcers (58%) were the most frequent dermatological lesions. A diffuse pattern of distribution of the skin lesions was found in 58% of the cases. There was significant association between the CD4+ cell counts and the morphological variability of lesions per patient. Variation in the lesions seemed to be associated with higher CD4+ cell counts. Doctors caring for HIV-infected patients should be aware of the wide spectrum of dermatological lesions observed in disseminated histoplasmosis and the importance of detecting and isolating the fungus in mucocutaneous tissues.Keywords
This publication has 22 references indexed in Scilit:
- Unusual manifestations of histoplasmosisDiagnostic Microbiology and Infectious Disease, 2004
- HistoplasmosisInfectious Disease Clinics of North America, 2003
- Differences in Histoplasmosis in Patients with Acquired Immunodeficiency Syndrome in the United States and BrazilThe Journal of Infectious Diseases, 2002
- Safety and Efficacy of Liposomal Amphotericin B Compared with Conventional Amphotericin B for Induction Therapy of Histoplasmosis in Patients with AIDSAnnals of Internal Medicine, 2002
- Disseminated cutaneous histoplasmosis in patients infected with human immunodeficiency virusJournal of Cutaneous Pathology, 2002
- Emergence of Resistance to Fluconazole as a Cause of Failure during Treatment of Histoplasmosis in Patients with Acquired Immunodeficiency Disease SyndromeClinical Infectious Diseases, 2001
- Disseminated Histoplasmosis and AIDS: Clinical Aspects and Diagnostic Methods for Early DetectionAIDS Patient Care and STDs, 2000
- HIV INFECTION AND AIDS IN LATIN AMERICAInfectious Disease Clinics of North America, 1994
- Histoplasmosis in individuals with acquired immunodeficiency syndrome (AIDS): Report of six cases with cutaneous-mucosal involvementMycopathologia, 1991
- Disseminated Histoplasmosis in the Acquired Immune Deficiency SyndromeMedicine, 1990